Balance Sheet Breakdown: Adicet Bio Inc (ACET)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

After finishing at $1.35 in the prior trading day, Adicet Bio Inc (NASDAQ: ACET) closed at $1.31, down -2.96%. In other words, the price has decreased by -$2.96 from its previous closing price. On the day, 0.56 million shares were traded. ACET stock price reached its highest trading level at $1.37 during the session, while it also had its lowest trading level at $1.27.


Our goal is to gain a better understanding of ACET by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.34 and its Current Ratio is at 14.34. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.

JP Morgan Downgraded its Overweight to Neutral on June 01, 2023, whereas the target price for the stock was revised from $20 to $6.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 05 ’24 when Kauffman Michael sold 5,900 shares for $1.43 per share. The transaction valued at 8,437 led to the insider holds 5,900 shares of the business.

ORBIMED ADVISORS LLC bought 3,125,000 shares of ACET for $7,500,000 on Jan 25 ’24. The Director now owns 7,526,359 shares after completing the transaction at $2.40 per share. On Jan 25 ’24, another insider, GORDON CARL L, who serves as the Director of the company, bought 3,125,000 shares for $2.40 each. As a result, the insider paid 7,500,000 and bolstered with 7,526,359 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACET now has a Market Capitalization of 107647288 and an Enterprise Value of -119905712.

Stock Price History:

Over the past 52 weeks, ACET has reached a high of $5.74, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is -26.24%, while the 200-Day Moving Average is calculated to be -30.13%.

Shares Statistics:

The stock has traded on average 1.25M shares per day over the past 3-months and 664220 shares per day over the last 10 days, according to various share statistics. A total of 82.17M shares are outstanding, with a floating share count of 66.12M. Insiders hold about 19.53% of the company’s shares, while institutions hold 75.40% stake in the company. Shares short for ACET as of 1715731200 were 6939179 with a Short Ratio of 5.53, compared to 1713139200 on 7853977. Therefore, it implies a Short% of Shares Outstanding of 6939179 and a Short% of Float of 10.0.

Earnings Estimates

The dynamic stock of Adicet Bio Inc (ACET) is currently being evaluated by a team of 8.0 analysts, each contributing to its current rating.On average, analysts expect EPS of -$0.36 for the current quarter, with a high estimate of -$0.3 and a low estimate of -$0.41, while EPS last year was -$0.75. The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.27 and low estimates of -$0.42.

Analysts are recommending an EPS of between -$1.22 and -$1.62 for the fiscal current year, implying an average EPS of -$1.45. EPS for the following year is -$1.58, with 9.0 analysts recommending between -$0.89 and -$3.33.

Most Popular